Ontario Teachers Pension Plan Board Has Raised Holding in Monsanto Co New (MON) by $1.04 Million as Share Value Rose; Cvs Health (CVS) Shareholder Newfocus Financial Group Has Trimmed Its Stake by $1.63 Million as Shares Declined

May 27, 2018 - By Peter Erickson

Monsanto Company (NYSE:MON) Logo

Newfocus Financial Group Llc decreased its stake in Cvs Health Corp (CVS) by 70% based on its latest 2017Q4 regulatory filing with the SEC. Newfocus Financial Group Llc sold 22,696 shares as the company’s stock declined 17.45% with the market. The institutional investor held 9,725 shares of the medical and nursing services company at the end of 2017Q4, valued at $705,000, down from 32,421 at the end of the previous reported quarter. Newfocus Financial Group Llc who had been investing in Cvs Health Corp for a number of months, seems to be less bullish one the $67.13B market cap company. The stock increased 1.40% or $0.91 during the last trading session, reaching $66.03. About 5.56M shares traded. CVS Health Corporation (NYSE:CVS) has declined 22.81% since May 27, 2017 and is downtrending. It has underperformed by 34.36% the S&P500.

Ontario Teachers Pension Plan Board increased its stake in Monsanto Co New (MON) by 1.82% based on its latest 2017Q4 regulatory filing with the SEC. Ontario Teachers Pension Plan Board bought 8,957 shares as the company’s stock rose 1.12% while stock markets declined. The institutional investor held 500,387 shares of the agricultural chemicals company at the end of 2017Q4, valued at $58.44M, up from 491,430 at the end of the previous reported quarter. Ontario Teachers Pension Plan Board who had been investing in Monsanto Co New for a number of months, seems to be bullish on the $55.82B market cap company. The stock increased 0.89% or $1.12 during the last trading session, reaching $126.5. About 5.03 million shares traded or 32.18% up from the average. Monsanto Company (NYSE:MON) has risen 3.06% since May 27, 2017 and is uptrending. It has underperformed by 8.49% the S&P500.

More notable recent CVS Health Corporation (NYSE:CVS) news were published by: 247Wallst.com which released: “Alibaba, CVS, Tesla and Other Earnings to Watch For This Week” on April 29, 2018, also Seekingalpha.com with their article: “We Are Playing The CVS Hand” published on May 11, 2018, Investorplace.com published: “Aetna Inc (AET) Slims and Trims Before Marriage to CVS” on May 01, 2018. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: Prnewswire.com and their article: “CVS Health Statement on Trump Administration Initiative to Reduce Drug Costs” published on May 11, 2018 as well as Fool.com‘s news article titled: “5 Things You’ll Want to Know About CVS Health’s Plans for 2018 and Beyond” with publication date: May 04, 2018.

Among 26 analysts covering CVS Health (NYSE:CVS), 19 have Buy rating, 0 Sell and 7 Hold. Therefore 73% are positive. CVS Health had 77 analyst reports since July 22, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Wednesday, January 17 by Robert W. Baird. Jefferies maintained the shares of CVS in report on Wednesday, October 18 with “Hold” rating. Citigroup maintained the shares of CVS in report on Thursday, August 17 with “Neutral” rating. Leerink Swann maintained the shares of CVS in report on Tuesday, November 7 with “Outperform” rating. On Friday, December 18 the stock rating was initiated by Barclays Capital with “Overweight”. The firm has “Hold” rating given on Thursday, August 20 by Deutsche Bank. The firm has “Hold” rating given on Tuesday, November 7 by Jefferies. The company was upgraded on Tuesday, January 30 by Needham. Morgan Stanley upgraded the shares of CVS in report on Friday, January 5 to “Overweight” rating. The stock of CVS Health Corporation (NYSE:CVS) earned “Buy” rating by Raymond James on Thursday, January 4.

Investors sentiment decreased to 0.72 in 2017 Q4. Its down 0.16, from 0.88 in 2017Q3. It turned negative, as 115 investors sold CVS shares while 600 reduced holdings. 134 funds opened positions while 380 raised stakes. 815.59 million shares or 1.76% more from 801.45 million shares in 2017Q3 were reported. First State Bank Of Omaha has 0.08% invested in CVS Health Corporation (NYSE:CVS) for 16,484 shares. Guardian Life Ins Of America holds 3,292 shares. Metropolitan Life Insur invested 0.15% of its portfolio in CVS Health Corporation (NYSE:CVS). Clean Yield reported 0.99% stake. Northeast Management, a Massachusetts-based fund reported 287,431 shares. Northern Corporation has 0.29% invested in CVS Health Corporation (NYSE:CVS). 222,903 were accumulated by Eastern Fincl Bank. 10,200 are held by Saturna Cap Corp. Excalibur Mngmt reported 0.85% in CVS Health Corporation (NYSE:CVS). Bb&T Corp reported 172,922 shares. Brandes Investment LP holds 60,383 shares. Nuveen Asset Limited Liability Corporation accumulated 0.3% or 638,195 shares. 3,939 are held by Sns Fincl Grp Limited Liability Corporation. Dupont Cap Management invested 0.34% in CVS Health Corporation (NYSE:CVS). 2,907 were accumulated by Alpha Windward Limited Liability.

Since February 16, 2018, it had 2 buys, and 1 sale for $713,454 activity. Another trade for 10,000 shares valued at $619,900 was bought by BROWN C DAVID II. 24,300 CVS Health Corporation (NYSE:CVS) shares with value of $1.51M were bought by DORMAN DAVID W.

Analysts await CVS Health Corporation (NYSE:CVS) to report earnings on August, 14. They expect $1.61 EPS, up 21.05% or $0.28 from last year’s $1.33 per share. CVS’s profit will be $1.64B for 10.25 P/E if the $1.61 EPS becomes a reality. After $1.48 actual EPS reported by CVS Health Corporation for the previous quarter, Wall Street now forecasts 8.78% EPS growth.

Ontario Teachers Pension Plan Board, which manages about $8.12B US Long portfolio, decreased its stake in Devon Energy Corp New (NYSE:DVN) by 7,760 shares to 241,305 shares, valued at $9.99 million in 2017Q4, according to the filing. It also reduced its holding in Varian Med Sys Inc (NYSE:VAR) by 3,377 shares in the quarter, leaving it with 81,418 shares, and cut its stake in Smucker J M Co (NYSE:SJM).

Since January 9, 2018, it had 0 buys, and 1 sale for $966,720 activity.

Among 23 analysts covering Monsanto Company (NYSE:MON), 10 have Buy rating, 1 Sell and 12 Hold. Therefore 43% are positive. Monsanto Company had 63 analyst reports since August 25, 2015 according to SRatingsIntel. The company was maintained on Thursday, August 27 by Piper Jaffray. Atlantic Securities upgraded Monsanto Company (NYSE:MON) on Tuesday, December 1 to “Overweight” rating. Wells Fargo maintained Monsanto Company (NYSE:MON) on Wednesday, January 17 with “Hold” rating. Stifel Nicolaus maintained Monsanto Company (NYSE:MON) on Friday, October 9 with “Buy” rating. The stock has “Hold” rating by Jefferies on Tuesday, October 17. The stock of Monsanto Company (NYSE:MON) earned “Hold” rating by RBC Capital Markets on Tuesday, September 5. The firm has “Neutral” rating given on Friday, August 18 by UBS. Barclays Capital maintained Monsanto Company (NYSE:MON) rating on Thursday, June 29. Barclays Capital has “Hold” rating and $12000 target. Bernstein upgraded Monsanto Company (NYSE:MON) on Monday, September 26 to “Mkt Perform” rating. The company was maintained on Thursday, October 8 by Deutsche Bank.

CVS Health Corporation (NYSE:CVS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Peter Erickson

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:








Recent Posts